CELZ - Creative Medical Technology Holdings Inc logo

Creative Medical Technology Holdings Inc

CELZ

Creative Medical Technology Holdings develops biological therapeutics for conditions like erectile dysfunction, infertility, and chronic pain, utilizing stem cell research. Its products include CaverStem, FemCelz, and various regenerative therapies for diverse indications.

⚕️ Healthcare NASDAQ Listed 2015 $ USD
$1,000 invested 10 years ago →$0today

Score Overview

1 Year
Score
Net Growth-0.76%
Net TrendShrank
Net Income Consistency—
Rev Growth-50.00%
Rev TrendShrank
Revenue Consistency—
5 Years
Score2.2
Net Growth-131.44%
Net Trend20%
Net Income Consistency—
Rev Growth-96.58%
Rev Trend40%
Revenue Consistency—
10 Years
Score—
Net Growth-5x
Net Trend30%
Net Income Consistency
Rev Growth—
Rev Trend50%
Revenue Consistency
All Time
Score—
Net Growth-194x
Net Trend27%
Net Income Consistency
Rev Growth—
Rev Trend45%
Revenue Consistency

Explore the 2021 public Archive ranking →

Where Creative Medical Technology Holdings Inc has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. CELZ does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-21
$ 0.74—
1 Year2025-10-21
$ 3.71-79.99%
5 Years2021-10-21
$ 79.28-99.06%
10 Years2016-08-26
$ 382.5K-100.00%
All Time2015-11-06
$ 8.25K-99.99%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 3K-$ 6M$ 8M
2025$ 6K-$ 5M$ 7M
2024$ 11K-$ 5M$ 5M
2023$ 9K-$ 5M$ 9M
2022$ 88.6K-$ 10M$ 18M
2021$ 87.75K$ 19M$ 10M
2020$ 164.5K-$ 36M$ 98.01K
2019$ 165.5K-$ 8M$ 88.65K
2018$ 124.4K-$ 13M$ 304.06K
2017$ 4.8K-$ 2M$ 13.7K
2016$ 0.00-$ 766.07K$ 221.87K
IPO2015$ 0.00-$ 30.76K$ 216.00
CELZ - Creative Medical Technology Holdings Inc logo

Creative Medical Technology Holdings Inc fundamental performance

Between 2020 and 2025, revenue declined from $ 164.5K to $ 6K and net income went from -$ 36M to -$ 5M. Revenue increased in 2 of those 5 years; net income in 1.

Creative Medical Technology Holdings Inc currently holds a 5-year HDB Score of 2.2 out of 10. How the HDB Score is calculated.

Membership

Explore CELZ with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,118 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year · Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies